{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:45:24Z","timestamp":1792590324188,"version":"4.5.0"},"reference-count":31,"publisher":"MyJove Corporation","issue":"229","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/69550","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T23:01:30Z","timestamp":1773442890000},"source":"Crossref","is-referenced-by-count":0,"title":["Lentiviral-induced Striatal Pathology as a Preclinical Model of Polyglutamine Spinocerebellar Ataxias"],"prefix":"10.3791","author":[{"given":"Tiago","family":"Moreira-Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas T.","family":"Afonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael G.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V. C.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Alexandre","family":"Ricardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9vio","family":"N\u00f3brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.3390\/ijms22084249","type":"journal-article","article-title":"Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias","volume":"22","author":"Afonso-Reis","year":"2021","unstructured":"Afonso-Reis, R., Afonso, I. T., N\u00f3brega, C. Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias. Int J Mol Sci. 22 (8), 4249 (2021).","journal-title":"Int J Mol Sci"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","type":"journal-article","article-title":"Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond","volume":"9","author":"Durr","year":"2010","unstructured":"Durr, A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 9 (9), 885-894 (2010).","journal-title":"Lancet Neurol"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3390\/biomedicines9111499","type":"journal-article","article-title":"Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies","volume":"9","author":"McIntosh","year":"2021","unstructured":"McIntosh, C. S., Li, D., Wilton, S. D., Aung-Htut, M. T. Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies. Biomedicines. 9 (11), 1499 (2021).","journal-title":"Biomedicines"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/brain\/awae012","type":"journal-article","article-title":"Viral-based animal models in polyglutamine disorders","volume":"147","author":"Henriques","year":"2024","unstructured":"Henriques, C. et al. Viral-based animal models in polyglutamine disorders. Brain. 147 (4), 1166-1189 (2024).","journal-title":"Brain"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11248-011-9537-3","type":"journal-article","article-title":"The Construction of Transgenic and Gene Knockout\/Knockin Mouse Models of Human Disease","volume":"21","author":"Doyle","year":"2012","unstructured":"Doyle, A., McGarry, M. P., Lee, N. A., Lee, J. J. The Construction of Transgenic and Gene Knockout\/Knockin Mouse Models of Human Disease. Transg Res. 21 (2), 327-349 (2012).","journal-title":"Transg Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"883358","DOI":"10.3389\/fnmol.2022.883358","type":"journal-article","article-title":"Animal Models of Neurodegenerative Disease: Recent Advances in Fly Highlight Innovative Approaches to Drug Discovery","volume":"15","author":"Tello","year":"2022","unstructured":"Tello, J. A., Williams, H. E., Eppler, R. M., Steinhilb, M. L., Khanna, M. Animal Models of Neurodegenerative Disease: Recent Advances in Fly Highlight Innovative Approaches to Drug Discovery. Front Mol Neurosci. 15, 883358 (2022).","journal-title":"Front Mol Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-0716-4807-0_18","type":"journal-article","article-title":"Development of a gene therapy with lentiviral vectors for spinocerebellar ataxias","volume":"2974","author":"Moreira-Gomes","year":"2026","unstructured":"Moreira-Gomes, T., N\u00f3brega, C. Development of a gene therapy with lentiviral vectors for spinocerebellar ataxias. Methods Mol Biol. 2974, 215-225 (2026).","journal-title":"Methods Mol Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2015.00014","type":"journal-article","article-title":"Lentiviral vectors as tools to understand central nervous system biology in mammalian model organisms","volume":"8","author":"Parr-Brownlie","year":"2015","unstructured":"Parr-Brownlie, L. C. et al. Lentiviral vectors as tools to understand central nervous system biology in mammalian model organisms. Front Mol Neurosci. 8, 14 (2015).","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/v17020239","type":"journal-article","article-title":"Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy","volume":"17","author":"Zwi-Dantsis","year":"2025","unstructured":"Zwi-Dantsis, L., Mohamed, S., Massaro, G., Moeendarbary, E. Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy. Viruses. 17 (2), 239 (2025).","journal-title":"Viruses"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/jnc.16010","type":"journal-article","article-title":"From the disruption of RNA metabolism to the targeting of RNA-binding proteins: The case of polyglutamine spinocerebellar ataxias","volume":"168","author":"Moreira-Gomes","year":"2024","unstructured":"Moreira-Gomes, T., N\u00f3brega, C. From the disruption of RNA metabolism to the targeting of RNA-binding proteins: The case of polyglutamine spinocerebellar ataxias. J Neurochem. 168 (8), 1442-1459 (2024).","journal-title":"J Neurochem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneumeth.2013.12.004","type":"journal-article","article-title":"Generation of a neurodegenerative disease mouse model using lentiviral vectors carrying an enhanced synapsin I promoter","volume":"223","author":"Matsuzaki","year":"2014","unstructured":"Matsuzaki, Y., Oue, M., Hirai, H. Generation of a neurodegenerative disease mouse model using lentiviral vectors carrying an enhanced synapsin I promoter. J Neurosci Meth. 223, 133-143 (2014).","journal-title":"J Neurosci Meth"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41419-021-04404-1","type":"journal-article","article-title":"Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy","volume":"12","author":"Marcelo","year":"2021","unstructured":"Marcelo, A. et al. Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy. Cell Death Dis. 12 (12), 1117 (2021).","journal-title":"Cell Death Dis"},{"issue":"14","key":"ref13","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddn106","type":"journal-article","article-title":"Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease","volume":"17","author":"Alves","year":"2008","unstructured":"Alves, S. et al. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease. Human Mol Genet. 17 (14), 2071-2083 (2008).","journal-title":"Human Mol Genet"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-016-0123-2","type":"journal-article","article-title":"Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS\/TLS and MBNL1 RNA-binding proteins","volume":"11","author":"Alves","year":"2016","unstructured":"Alves, S. et al. Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS\/TLS and MBNL1 RNA-binding proteins. Mol Neurodegenerat. 11 (1), 58 (2016).","journal-title":"Mol Neurodegenerat"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1472-6750-6-34","type":"journal-article","article-title":"Comparison of lentiviral vector titration methods","volume":"6","author":"Geraerts","year":"2006","unstructured":"Geraerts, M., Willems, S., Baekelandt, V., Debyser, Z., Gijsbers, R. Comparison of lentiviral vector titration methods. BMC Biotechnol. 6 (1), 34 (2006).","journal-title":"BMC Biotechnol"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3390\/biomedicines12102265","type":"journal-article","article-title":"Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors","volume":"12","author":"Arrasate","year":"2024","unstructured":"Arrasate, A. et al. Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors. Biomedicines. 12 (10), 2265 (2024).","journal-title":"Biomedicines"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12311-012-0432-0","type":"journal-article","article-title":"Overexpression of Mutant Ataxin-3 in Mouse Cerebellum Induces Ataxia and Cerebellar Neuropathology","volume":"12","author":"N\u00f3brega","year":"2013","unstructured":"N\u00f3brega, C. et al. Overexpression of Mutant Ataxin-3 in Mouse Cerebellum Induces Ataxia and Cerebellar Neuropathology. Cerebellum. 12 (4), 441-455 (2013).","journal-title":"Cerebellum"},{"key":"ref18","type":"book","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004","unstructured":"Paxinos, G., Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates: Compact Second Edition. Gulf Professional Publishing (2004)."},{"issue":"33","key":"ref19","doi-asserted-by":"crossref","first-page":"14845","DOI":"10.1073\/pnas.1009874107","type":"journal-article","article-title":"Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors","volume":"107","author":"Bateup","year":"2010","unstructured":"Bateup, H. S. et al. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc Natl Acad Sci U S A. 107 (33), 14845-14850 (2010).","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41419-025-08154-2","type":"journal-article","article-title":"Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxias","volume":"16","author":"N\u00f3brega","year":"2025","unstructured":"N\u00f3brega, C. et al. Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxias. Cell Death Dis. 16 (1), 826 (2025).","journal-title":"Cell Death Dis"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"101176","DOI":"10.1016\/j.omtm.2023.101176","type":"journal-article","article-title":"AAV-based gene therapy ameliorated CNS-specific GPI defect in mouse models","volume":"32","author":"Murakami","year":"2024","unstructured":"Murakami, Y. et al. AAV-based gene therapy ameliorated CNS-specific GPI defect in mouse models. Mol Ther Meth Clin Dev. 32 (1), 101176 (2024).","journal-title":"Mol Ther Meth Clin Dev"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1016\/j.ymthe.2025.07.055","type":"journal-article","article-title":"AAV-based gene therapy ameliorates neurological deficits in a mouse model of childhood-onset neurodegeneration with cerebellar atrophy","volume":"33","author":"Wada","year":"2025","unstructured":"Wada, H. et al. AAV-based gene therapy ameliorates neurological deficits in a mouse model of childhood-onset neurodegeneration with cerebellar atrophy. Mol Ther J Am Soc Gene Ther. 33 (11), 5829-5839 (2025).","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"13","key":"ref23","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.3390\/ijms25137205","type":"journal-article","article-title":"Production of Spinocerebellar Ataxia Type 3 Model Mice by Intravenous Injection of AAV-PHP.B Vectors","volume":"25","author":"Konno","year":"2024","unstructured":"Konno, A., Shinohara, Y., Hirai, H. Production of Spinocerebellar Ataxia Type 3 Model Mice by Intravenous Injection of AAV-PHP.B Vectors. Int J Mol Sci. 25 (13), 7205 (2024).","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"863089","DOI":"10.3389\/fcell.2022.863089","type":"journal-article","article-title":"Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model","volume":"10","author":"Jansen-West","year":"2022","unstructured":"Jansen-West, K. et al. Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model. Front Cell Dev Biol. 10, 863089 (2022).","journal-title":"Front Cell Dev Biol"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-41333-0","type":"book","volume-title":"A Handbook of Gene and Cell Therapy","author":"N\u00f3brega","year":"2020","unstructured":"N\u00f3brega, C., Mendon\u00e7a, L., Matos, C. A. A Handbook of Gene and Cell Therapy. Springer International Publishing. Cham (2020)."},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","type":"journal-article","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","unstructured":"Thomas, C. E., Ehrhardt, A., Kay, M. A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 4 (5), 346-358 (2003).","journal-title":"Nat Rev Genet"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/hum.2012.229","type":"journal-article","article-title":"Biosafety Features of Lentiviral Vectors","volume":"24","author":"Schambach","year":"2013","unstructured":"Schambach, A., Zychlinski, D., Ehrnstroem, B., Baum, C. Biosafety Features of Lentiviral Vectors. Human Gene Ther. 24 (2), 132-142 (2013).","journal-title":"Human Gene Ther"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","type":"journal-article","article-title":"Lentiviral-Mediated Delivery of Mutant Huntingtin in the Striatum of Rats Induces a Selective Neuropathology Modulated by Polyglutamine Repeat Size, Huntingtin Expression Levels, and Protein Length","volume":"22","author":"de Almeida","year":"2002","unstructured":"Almeida, L. P. de, Ross, C. A., Zala, D., Aebischer, P., D\u00e9glon, N. Lentiviral-Mediated Delivery of Mutant Huntingtin in the Striatum of Rats Induces a Selective Neuropathology Modulated by Polyglutamine Repeat Size, Huntingtin Expression Levels, and Protein Length. J Neurosci. 22 (9), 3473-3483 (2002).","journal-title":"J Neurosci"},{"issue":"493","key":"ref29","doi-asserted-by":"crossref","first-page":"eaaq1818","DOI":"10.1126\/scitranslmed.aaq1818","type":"journal-article","article-title":"Mouse models of neurodegeneration: Know your question, know your mouse","volume":"11","author":"Fisher","year":"2019","unstructured":"Fisher, E. M. C., Bannerman, D. M. Mouse models of neurodegeneration: Know your question, know your mouse. Sci Transl Med. 11 (493), eaaq1818 (2019).","journal-title":"Sci Transl Med"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"15451","DOI":"10.18632\/oncotarget.24503","type":"journal-article","article-title":"Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes","volume":"9","author":"Bii","year":"2018","unstructured":"Bii, V. M., Collins, C. P., Hocum, J. D., Trobridge, G. D. Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes. Oncotarget. 9 (21), 15451-15463 (2018).","journal-title":"Oncotarget"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3389\/fnins.2016.00572","type":"journal-article","article-title":"Motor Dysfunctions and Neuropathology in Mouse Models of Spinocerebellar Ataxia Type 2: A Comprehensive Review","volume":"10","author":"Alves-Cruzeiro","year":"2016","unstructured":"Alves-Cruzeiro, J. M. D. C., Mendon\u00e7a, L., Pereira de Almeida, L., N\u00f3brega, C. Motor Dysfunctions and Neuropathology in Mouse Models of Spinocerebellar Ataxia Type 2: A Comprehensive Review. Front Neurosci. 10, 572 (2016).","journal-title":"Front Neurosci"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/69550\/lentiviral-induced-striatal-pathology-as-preclinical-model","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:16:12Z","timestamp":1792588572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/69550\/lentiviral-induced-striatal-pathology-as-preclinical-model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":31,"journal-issue":{"issue":"229","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/69550","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]}}}